Cited by 421Receptor Mechanisms and SignalingProtein Kinase Regulation and GTPase SignalingNeuroscience and Neuropharmacology Research

Cellular expression of the carboxyl terminus of a G protein-coupled receptor kinase attenuates G beta gamma-mediated signaling.

Open access
Koch, W.J., Hawes, B.E., Inglese, J., Luttrell, L.M., Lefkowitz, R.J.·1994·Journal of Biological Chemistry

Abstract

The beta gamma subunits (G beta gamma) of heterotrimeric G proteins modulate the activity of several signal-transducing effector molecules including G protein-coupled receptor kinases. G beta gamma binds to the carboxyl terminus of the beta-adrenergic receptor kinase (beta ARK) and regulates its activity. To investigate the effect of such a G beta gamma-binding domain on heterologous G beta gamma interactions, various receptors that can stimulate phospholipase C and/or type II adenylate cyclase were coexpressed in COS-7 cells with the carboxyl terminus of beta ARK1. Phosphoinositol hydrolysis in response to activation of receptors that stimulate phospholipase C via Gi beta gamma (alpha 2-adrenergic and M2-muscarinic cholinergic receptors) was markedly inhibited by the coexpressed beta ARK1 polypeptide, whereas that mediated by Gq alpha subunits (alpha 1-adrenergic and M1-muscarinic cholinergic receptors) was unaffected. Increased cellular cAMP levels due to stimulation of receptors and coexpressed adenylate cyclase II displayed marked inhibition in the presence of the beta ARK1 polypeptide. Moreover, inhibition of adenylate cyclase produced by alpha 2-adrenergic receptor stimulation (a Gi alpha-mediated process) was unaffected, indicating that the beta ARK1 polypeptide provides a useful tool for distinguishing between G alpha and G beta gamma pathways.

Integrity signals

Registry

Crossref · 10.1016/s0021-9258(17)37587-7

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Coexpression of bARKct restored GEF-H1-eGFP localization to the microtubules.

    “To demonstrate the specificity of the Gbg effect on GEF-H1 redistribution, we co-expressed the Gbg-specific antagonist peptide, bARKct, derived from the Gbg-binding domain of b-adrenergic receptor kinase 1, which specifically inhibits Gbg-dependent signalling 16 , and noted that coexpression of bARKct restored GEF-H1-eGFP localization to the microtubules (Fig. 2c; Supplementary Fig. 2a).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Koch, W. J., Hawes, B. E., Inglese, J., Luttrell, L. M., & Lefkowitz, R. J.
Affiliations
Howard Hughes Medical Institute (US)
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
1994-02
Volume
269
Issue
8
Pages
6193-6197
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2160146943
Cited by
421
References
2
Citations by year
2026: 5 · 2025: 4 · 2024: 5 · 2023: 2 · 2022: 4 · 2021: 3 · 2020: 4 · 2019: 9 · 2018: 7 · 2017: 5 · 2016: 9 · 2015: 4 · 2014: 8 · 2013: 11 · 2012: 6
FWCI
7.82
Type
journal article
Language
en
Open access
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
National Heart, Lung, and Blood Institute (HL 16037)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
beta-adrenergic receptor kinase, heterotrimeric G proteins, phosphoinositide hydrolysis, phospholipase C, cyclic AMP, alpha2-adrenoceptors, muscarinic receptors, Gi alpha, Gαq
MeSH terms
Adenylyl Cyclases, Animals, Base Sequence, Cattle, Cell Line, Enzyme Activation, Molecular Sequence Data, Oligodeoxyribonucleotides, Peptide Fragments, Type C Phospholipases, Signal Transduction, Cyclic AMP-Dependent Protein Kinases, GTP-Binding Proteins, beta-Adrenergic Receptor Kinases, Cyclic AMP-Dependent Protein Kinase Type II

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review